Source: Eur Respir J 2012; 40: 1576-1578
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Wouter Hoefsloot, Martin J. Boeree, Cees van Nieuwkoop, Alexandra T. Bernards, Paul H.M. Savelkoul, Jakko van Ingen, Dick van Soolingen. No human transmission of Mycobacterium malmoense in a perfect storm setting. Eur Respir J 2012; 40: 1576-1578

Member's Comments

No comment yet.

Related content which might interest you: Human-to-human transmission of Mycobacterium kansasii or victims of a shared source? Source: Eur Respir J 2014; 44: 1085-1087 Year: 2014 Recurrent laboratory pseudo-outbreaks of Mycobacterium intracellulare Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Clinical relevance of Mycobacterium malmoense isolation in the Netherlands Source: Eur Respir J 2009; 34: 926-931 Year: 2009 Pulmonary diseases caused by non-tuberculous mycobacteria Source: Eur Respir Mon 2012; 58: 25-37 Year: 2012 Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Animal-to-human transmission of Mycobacterium pinnipedii Source: Eur Respir J, 56 (6) 2000371; 10.1183/13993003.00371-2020 Year: 2020 Mycobacterium xenopi pulmonary disease in Croatia Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016 Year: 2017 Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis Source: Eur Respir J 2010; 35: 692-694 Year: 2010 Invasive Mycobacterium avium intracellulare infection Source: Eur Respir J 2006; 28: Suppl. 50, 312s Year: 2006 The spectrum of drug susceptibility of slow-growing nontuberculous mycobacteria (MAC, M. kansasii, M. xenopi) Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Mycobacterium avium complex infection: phenotypes and outcomes Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017 Year: 2017 Residential bathroom is a candidate for source of pulmonary mycobacterium avium complex infection Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006 Genotyping of human Mycobacterium kansasii isolates from Poland. Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections Source: Eur Respir J, 49 (5) 1700083; 10.1183/13993003.00083-2017 Year: 2017 Transmission of Mycobacterium tuberculosis to households of tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 197s Year: 2005 Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005